Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 19, pp. 5485-5493
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 8, 2013
- Revision received June 17, 2013
- Accepted June 30, 2013
- Published first August 6, 2013.
Article Versions
- Previous version (August 6, 2013 - 05:51).
- Previous version (September 23, 2013 - 09:15).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Joo Ern Ang1,
- Charlie Gourley2,
- C. Bethan Powell6,
- Hilda High7,
- Ronnie Shapira-Frommer8,
- Vincent Castonguay9,
- Jacques De Greve10,
- Tina Atkinson11,
- Timothy A. Yap1,
- Shahneen Sandhu1,
- Susana Banerjee1,
- Lee-May Chen6,
- Michael L. Friedlander7,
- Bella Kaufman8,
- Amit M. Oza9,
- Ursula Matulonis11,
- Louise J. Barber3,4,
- Iwanka Kozarewa5,
- Kerry Fenwick5,
- Ioannis Assiotis5,
- James Campbell3,4,5,
- Lina Chen5,
- Johann S. de Bono1,
- Martin E. Gore1,
- Christopher J. Lord3,4,
- Alan Ashworth3,4, and
- Stan B. Kaye1
- Authors' Affiliations: 1The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton; 2Edinburgh Cancer Research UK Center, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh; 3The Cancer Research UK Gene Function Laboratory; 4Breakthrough Breast Cancer Research Center; 5Tumour Profiling Unit, The Institute of Cancer Research, London, United Kingdom; 6University of California San Francisco, San Francisco, California; 7Department of Medical Oncology, Prince of Wales Clinical School, Prince of Wales Hospital, Sydney, Australia; 8The Chaim Sheba Medical Center, Tel Hashomer, Israel; 9Princess Margaret Hospital, Toronto, Canada; 10Oncologisch Centrum Vrije Universiteit Brussel, Brussels, Belgium; and 11Dana Farber Cancer Center, Boston, Massachusetts
- Corresponding Author:
Stan B. Kaye, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, 15 Cotswold Road, Sutton, Surrey SM2 5PT, United Kingdom. Phone: 44-20-8661-3539; Fax: 44-20-8661-3541; E-mail: stan.kaye{at}rmh.nhs.uk
October 2013
Volume 19, Issue 19
Volume 19, Issue 19
Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study
Jump to section
Advertisement